Anais da Academia Brasileira de Ciências (2009) The present issue of the Anais da Academia Brasileira de Ciências includes peer-reviewed articles contribu scientists that participated in the workshop "Science and Technology to Combat Dengue Virus" promoted Brazilian Academy of Sciences (June 5-6, 2008 ). The Dengue virus (DENV) is a member of the virus Flaviviridae and is transmitted to humans through the bite of the mosquito Aedes aegypti and, more rarely, by albopictus. Dengue virus is the most common arthropod-borne disease in the world. Global epidemics of have occurred, in part, due to a reduced commitment with regard to the control of mosquitoes coupled with factors, such as increase of population in urban areas.
According to the World Health Organization, more than 50 million cases of infection caused by DENV are est to occur annually. Dengue is mainly found in the tropics because the mosquitoes require a warm climate. The m of deaths that result from dengue infection is due to Dengue Hemorrhagic Fever (DHF) and Dengue Shock Syn (DSS). It is believed that sequential infection by multiple serotypes of DENV can lead to the development of and it has been estimated close to 500 thousand cases per year worldwide. The Dengue virus has 4 subtyp share about 60-80% homology among each other. The major difference lies in the proteins present in the mem envelope. Infection with a particular DENV subtype leads to the development of an immune response. Ho when an individual is infected with another subtype, the immune response might not work perfectly, which ma the antibodies to bind to the surface proteins but with failure to inactivate the virus. It is believed that DHF result from an antibody-dependent enhancement (ADE), when the viral particles coated with antibodies are by macrophages, followed by the release of cytokines that cause the endothelial tissue to become permeable, results in hemorrhagic fever and fluid loss from the blood vessels. The basic treatment of DHF is to preven loss, which usually requires hospitalization in intensive care units. This poses a big burden to the health sys countries affected by the disease. Because a tetravalent vaccine is not available yet, the most effective prev measures lie in mosquito control. 
